FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308367583> ?p ?o ?g. }

• W4308367583 endingPage "693" @default.
• W4308367583 startingPage "687" @default.
• W4308367583 abstract "Abstract Aims To study if any qualitative or quantitative optical coherence tomography (OCT) variables in combination with thin cap fibroatheroma (TCFA) patients could improve the identification of lesions at risk for future major adverse cardiac events (MACEs). Methods and results From the combined optical coherence tomography morphologic and fractional flow reserve hemodynamic assessment of non- culprit lesions to better predict adverse event outcomes in diabetes mellitus patients: COMBINE (OCT-FFR) trial database (NCT02989740), we performed a detailed assessment OCT qualitative and quantitative variables in TCFA carrying diabetes mellitus (DM) patients with vs. without MACE during follow-up. MACEs were defined as a composite of cardiac death, target vessel myocardial infarction, clinically driven target lesion revascularization, and hospitalization for unstable angina. From the 390 fractional flow reserve (FFR)-negative DM patients, 98 (25.2%) had ≥1 OCT-detected TCFA, of which 13 (13.3%) had MACE and 85 (86.7%) were event-free (non-MACE). The baseline characteristics were similar between both groups; however, a smaller minimal lumen area (MLA) and lower mean FFR value were observed in MACE group (1.80 vs. 2.50 mm2, P = 0.01, and 0.85 vs. 0.89, P = 0.02, respectively). Prevalence of healed plaque (HP) was higher in the MACE group (53.85 vs. 21.18%, P = 0.01). TCFA were predominantly located proximal to the MLA. TCFA area was smaller in the MACE group, while no difference was observed regarding the lesion area. Conclusion Within TCFA carrying patients, a smaller MLA, lower FFR values, and TCFA location adjacent to a HP were associated with future MACE. Carpet-like measured lesion area surface was similar, while the TCFA area was smaller in the MACE arm, and predominantly located proximal to the MLA." @default.
• W4308367583 created "2022-11-11" @default.
• W4308367583 creator A5002885109 @default.
• W4308367583 creator A5005102482 @default.
• W4308367583 creator A5005405403 @default.
• W4308367583 creator A5005914128 @default.
• W4308367583 creator A5005958154 @default.
• W4308367583 creator A5012837780 @default.
• W4308367583 creator A5012850746 @default.
• W4308367583 creator A5017782644 @default.
• W4308367583 creator A5023867414 @default.
• W4308367583 creator A5025131854 @default.
• W4308367583 creator A5027384327 @default.
• W4308367583 creator A5038023660 @default.
• W4308367583 creator A5043202330 @default.
• W4308367583 creator A5047328504 @default.
• W4308367583 creator A5057368267 @default.
• W4308367583 creator A5061454014 @default.
• W4308367583 creator A5062318295 @default.
• W4308367583 creator A5063256603 @default.
• W4308367583 creator A5063357240 @default.
• W4308367583 creator A5067474210 @default.
• W4308367583 creator A5072373889 @default.
• W4308367583 creator A5073430315 @default.
• W4308367583 creator A5077305881 @default.
• W4308367583 creator A5078042809 @default.
• W4308367583 creator A5080359871 @default.
• W4308367583 creator A5084752627 @default.
• W4308367583 date "2022-11-07" @default.
• W4308367583 modified "2023-10-11" @default.
• W4308367583 title "Morphological characteristics of lesions with thin cap fibroatheroma—a substudy from the COMBINE (OCT-FFR) trial" @default.
• W4308367583 cites W147178430 @default.
• W4308367583 cites W1956305767 @default.
• W4308367583 cites W2108234186 @default.
• W4308367583 cites W2438215896 @default.
• W4308367583 cites W2494748771 @default.
• W4308367583 cites W2530068698 @default.
• W4308367583 cites W2551730582 @default.
• W4308367583 cites W2616076707 @default.
• W4308367583 cites W2626614396 @default.
• W4308367583 cites W2946677191 @default.
• W4308367583 cites W2965245115 @default.
• W4308367583 cites W3045984961 @default.
• W4308367583 cites W3135498932 @default.
• W4308367583 cites W3161896957 @default.
• W4308367583 cites W3163922783 @default.
• W4308367583 cites W3168844296 @default.
• W4308367583 cites W3191267295 @default.
• W4308367583 cites W4200331052 @default.
• W4308367583 cites W4225595716 @default.
• W4308367583 cites W4236067666 @default.
• W4308367583 cites W75129238 @default.
• W4308367583 doi "https://doi.org/10.1093/ehjci/jeac218" @default.
• W4308367583 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36342269" @default.
• W4308367583 hasPublicationYear "2022" @default.
• W4308367583 type Work @default.
• W4308367583 citedByCount "4" @default.
• W4308367583 countsByYear W43083675832022 @default.
• W4308367583 countsByYear W43083675832023 @default.
• W4308367583 crossrefType "journal-article" @default.
• W4308367583 hasAuthorship W4308367583A5002885109 @default.
• W4308367583 hasAuthorship W4308367583A5005102482 @default.
• W4308367583 hasAuthorship W4308367583A5005405403 @default.
• W4308367583 hasAuthorship W4308367583A5005914128 @default.
• W4308367583 hasAuthorship W4308367583A5005958154 @default.
• W4308367583 hasAuthorship W4308367583A5012837780 @default.
• W4308367583 hasAuthorship W4308367583A5012850746 @default.
• W4308367583 hasAuthorship W4308367583A5017782644 @default.
• W4308367583 hasAuthorship W4308367583A5023867414 @default.
• W4308367583 hasAuthorship W4308367583A5025131854 @default.
• W4308367583 hasAuthorship W4308367583A5027384327 @default.
• W4308367583 hasAuthorship W4308367583A5038023660 @default.
• W4308367583 hasAuthorship W4308367583A5043202330 @default.
• W4308367583 hasAuthorship W4308367583A5047328504 @default.
• W4308367583 hasAuthorship W4308367583A5057368267 @default.
• W4308367583 hasAuthorship W4308367583A5061454014 @default.
• W4308367583 hasAuthorship W4308367583A5062318295 @default.
• W4308367583 hasAuthorship W4308367583A5063256603 @default.
• W4308367583 hasAuthorship W4308367583A5063357240 @default.
• W4308367583 hasAuthorship W4308367583A5067474210 @default.
• W4308367583 hasAuthorship W4308367583A5072373889 @default.
• W4308367583 hasAuthorship W4308367583A5073430315 @default.
• W4308367583 hasAuthorship W4308367583A5077305881 @default.
• W4308367583 hasAuthorship W4308367583A5078042809 @default.
• W4308367583 hasAuthorship W4308367583A5080359871 @default.
• W4308367583 hasAuthorship W4308367583A5084752627 @default.
• W4308367583 hasConcept C126322002 @default.
• W4308367583 hasConcept C126838900 @default.
• W4308367583 hasConcept C134018914 @default.
• W4308367583 hasConcept C141071460 @default.
• W4308367583 hasConcept C164705383 @default.
• W4308367583 hasConcept C2777785093 @default.
• W4308367583 hasConcept C2777987666 @default.
• W4308367583 hasConcept C2778710248 @default.
• W4308367583 hasConcept C2778818243 @default.
• W4308367583 hasConcept C2780400711 @default.
• W4308367583 hasConcept C2780739214 @default.
• W4308367583 hasConcept C2781156865 @default.

• next